Evidence map›Paper›PMID 24977104›Full record

ArticleJournal of clinical & experimental ophthalmology2013

Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy.

Kailun Jiang, Sijia Cao, Jing Z Cui, Joanne A Matsubara

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical & experimental ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. The applicability of the MigratestBMC veterinary research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of Inflammation in Age-Related Macular Degeneration.International journal of biological sciences · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kailun JiangDepartment of Ophthalmology and Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.
Sijia CaoDepartment of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver BC, Canada.
Jing Z CuiDepartment of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver BC, Canada.
Joanne A MatsubaraDepartment of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver BC, Canada.
University of Ottawa · CA

Funding

CIHR 97806-1PHS HHS 97806-1
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a neurodegenerative disease characterized by retinal cell atrophy, and/or choroidal neovascularization in the macula and constitutes the most common cause of blindness among the elderly in industrialized countries. The management of AMD is constrained by our insufficient knowledge of its underlying mechanisms. Recent studies point towards an emerging involvement of interferon-gamma (IFN-γ), a soluble cytokine associated with innate and adaptive immunity. IFN-γ promotes proinflammatory responses by activating proinflammatory cytokines and chemokines, thereby recruiting immune cells such as macrophages and T cells. On the other hand, IFN-γ modulates inflammatory response by upregulating anti-inflammatory factors or inhibiting development of immune cells related to autoimmune response. The complex role of IFN-γ in AMD pathogenesis is intriguing and worth further investigation in terms of therapeutic development.

Indexed as

Age-related macular degenerationCXCL11CytokinesDrusenInterferon gammaPro-inflammatory modulationRPESTAT1

Identifiers

PMID24977104
PMCPMC4071053
OpenAlexW2115780902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.